AUTL
Autolus Therapeutics
AUTL
AUTL
89 hedge funds and large institutions have $277M invested in Autolus Therapeutics in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 96 → 89 (-7)
11% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 28
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Holders
89
Holding in Top 10
3
Calls
$583K
Puts
$20K
Top Buyers
| 1 | +$6.13M | |
| 2 | +$5.16M | |
| 3 | +$2.92M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$1.62M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$717K |
Top Sellers
| 1 | -$7.51M | |
| 2 | -$4.19M | |
| 3 | -$2.85M | |
| 4 |
Renaissance Technologies
New York
|
-$2.73M |
| 5 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
-$784K |
